Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/73424, first published .
Impact of the Exposome in Type 1 Diabetes: Protocol for a Scoping Review

Impact of the Exposome in Type 1 Diabetes: Protocol for a Scoping Review

Impact of the Exposome in Type 1 Diabetes: Protocol for a Scoping Review

Maurane Rollet   1, 2 , MSc ;   Gloria A Aguayo   1 , MD, PhD ;   Jean-Pierre Riveline   3, 4 , MD, PhD ;   Emmanuel Cosson   5, 6 , MD, PhD ;   Guy Fagherazzi   1 , PhD

1 Deep Digital Phenotyping Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg

2 Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg

3 Immediab Lab, Hôpital Necker-Enfants Malades, Paris, France

4 Department of Diabetes, Lariboisière Hospital, Assistance Publique – Hôpitaux de Paris, Paris, France

5 Nutritional Epidemiology Research Team (EREN), Université Sorbonne Paris Nord and Université Paris Cité, Centre de Recherche Épidémiologie et Statistique, Paris, France

6 Department of Endocrinology-Diabetology-Nutrition, AP-HP, Avicenne Hospital, Université Paris 13, Sorbonne Paris Cité, CRNH-IdF, CINFO, Bobigny, France

Corresponding Author:

  • Guy Fagherazzi, PhD
  • Deep Digital Phenotyping Research Unit
  • Department of Precision Health
  • Luxembourg Institute of Health
  • 1 A-B, Rue Thomas Edison
  • Strassen L-1445
  • Luxembourg
  • Phone: 352 26970-457
  • Email: guy.fagherazzi@lih.lu